As shown in Figure 2A, the tumor growth rate for MDA-MB-231-shDDX3 (60% decrease in DDX3 transcript), as anticipated from the in vitro study (Figure 1D), was initially slower than that of MDA-MB-231-shLuc during the first 6 weeks of the study. This evidence concerns the gene DDX3X and neoplasm.